SignalFDA/Bio

ABBVIE REPORTS POSITIVE PHASE 2 DATA FOR ZUMILOKIBART IN ATOPIC DERMATITIS - SEEKINGALPHA

Positive Phase 2 data for zumilokibart in atopic dermatitis signals clinical catalyst.

What changed

Positive Phase 2 data for zumilokibart in atopic dermatitis signals clinical catalyst.

Why it matters

Positive Phase 2 data for zumilokibart in atopic dermatitis signals clinical catalyst. — impact context not separately stored; see What changed.

Sources